Ezetimibe/Rosuvastatin Calcium/Candesartan Cilexetil/Amlodipine
- Generic Name
- Ezetimibe/Rosuvastatin Calcium/Candesartan Cilexetil/Amlodipine
To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
Phase 3
- Conditions
- HypertensionPrimary Hypercholesterolaemia
- Interventions
- Drug: Candesartan/Amlodipine
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Hyundai Pharm
- Target Recruit Count
- 125
- Registration Number
- NCT06646354
- Locations
- 🇰🇷
Hanyang University Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath